Adam Sampson-Johannes

Author

Cellular Engineering Technologies (United States)

Also Known As

A Sampson-Johannes, A. Sampson-Johannes, A. Sampson‐Johannes, ADAM SAMPSON‐JOHANNES, Adam Sampson-Johannes, Tompkins, S. Mark

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Cellular Engineering Technologies (United States)Cerus (United States)

About

Adam Sampson-Johannes is an author at Cellular Engineering Technologies (United States) specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	4.4K
2	Immunology	8	8	2.6K
3	Cell Biology	4	4	2.6K
4	Cellular Physiology	1	1	728
5	Molecular Biology	1	1	54

Adam Sampson-Johannes

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells James R. Bischoff, David H. Kirn, Angelica Williams, Science Mutant AdenovirusAdenovirus MutantFunctional P53Mutant AdenovirusesMedicine	1996	1.8K
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Carla Heise, Adam Sampson-Johannes, Angelica Williams, Nature Medicine Tumor BiologyCancer-associated VirusOncogenic AgentMedicineTumor-specific Cytolysis	1997	944
Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity Stephen Haskill, Amer A. Beg, S. Mark Tompkins, Cell InflammationImmediate-early GeneCytokineIκb-like ActivityCell Interaction	1991	728
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy Carla Heise, Terry Hermiston, Leisa Johnson, Nature Medicine Tumor BiologyMedicineAdenovirus E1a MutantImmunologyPathology	2000	584
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor P Ralph, Ilona Nakoinz, Adam Sampson-Johannes, The Journal of Immunology	1992	227
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity Dirk G. Brockstedt, Keith S. Bahjat, Martin Giedlin, Nature Medicine VaccinationVaccine DevelopmentVaccine TargetImmunologyT Cell Immunity	2005	133
Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. Adam Sampson-Johannes, J A Carlino The Journal of Immunology	1988	75
Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status Carla Heise, Ian Ganly, Y T Kim, Gene Therapy P53 StatusReplication-selective AdenovirusViral ReplicationMedicineGynecology	2000	66
Biological Properties and Molecular Biology of the Human Macrophage Growth Factor, CSF-1 P Ralph, M K Warren, Ilona Nakoinz, Immunobiology InflammationMacrophage BiologyCytokineHuman GrowthImmunology	1986	54
Developing Novel Oncolytic Adenoviruses through Bioselection Wen Yan, Galila Kitzes, Farid Dormishian, Journal of Virology Amino AcidsImmunologyPathologyEnhanced Oncolytic ActivityCancer Biology	2003	54

Page 1